MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 107 filers reported holding MENLO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $219,000 | +271.2% | 125,890 | +478.1% | 0.00% | – |
| Q1 2020 | $59,000 | -19.2% | 21,775 | +37.9% | 0.00% | – |
| Q4 2019 | $73,000 | +108.6% | 15,787 | +100.1% | 0.00% | – |
| Q3 2019 | $35,000 | -43.5% | 7,889 | -23.7% | 0.00% | – |
| Q2 2019 | $62,000 | +129.6% | 10,335 | +212.3% | 0.00% | – |
| Q1 2019 | $27,000 | +2600.0% | 3,309 | +1086.0% | 0.00% | – |
| Q4 2018 | $1,000 | -97.3% | 279 | -92.7% | 0.00% | – |
| Q3 2018 | $37,000 | +640.0% | 3,843 | +495.8% | 0.00% | – |
| Q2 2018 | $5,000 | -90.0% | 645 | -51.5% | 0.00% | – |
| Q1 2018 | $50,000 | – | 1,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 4,359,030 | $7,541,000 | 8.27% |
| Healthcare Value Capital, LLC | 1,700,000 | $2,941,000 | 7.51% |
| 683 Capital Management, LLC | 5,550,208 | $9,602,000 | 0.77% |
| Perceptive Advisors | 22,876,410 | $39,576,000 | 0.64% |
| Vivo Capital, LLC | 3,643,824 | $6,304,000 | 0.45% |
| Monashee Investment Management LLC | 1,005,000 | $1,739,000 | 0.26% |
| MYDA Advisors LLC | 93,300 | $161,000 | 0.10% |
| Sofinnova Investments, Inc. | 725,571 | $1,256,000 | 0.08% |
| CAAS CAPITAL MANAGEMENT LP | 1,185,501 | $2,051,000 | 0.07% |
| Grace Capital | 36,012 | $62,000 | 0.05% |